vinflunine,docetaxel,erdafitinib,pembrolizumab
pierre fabre,merck,janssen
['erdafitinib', 'thor study', 'muc ,(-much)']
 groundbreaking session by dr. loriot discussing results in phase 3 thor study . supporting the use of erdafitinib as the standard of care for muc with fgralt after anti-pd-(l)1 treatment. os hr=0.64, pfs hr=0.58 #asco23 #cancerresearch 
Medical Oncologist at Centro Oncológico Integral, Hospital Ángeles Puebla. Cancer treatment must be personalized to the individual needs of the patient.